Dr. Tyrone C. Malloy: Family Planning
Randomized Oral V. Vaginal
Misoprostol at 24 Hours After
Mifepristone for Abortion up to
63 Days Gestation.
Principal Investigator
Role of Routine Ultrasound with Mifepristone and Vaginal Misoprostol
for Abortion up to 63 Days Gestation.
Principal Investigator
Constipation A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Multi-Site Study to Evaluate the Clinical Equivalence of XXXX with XXXX in the Treatment of Chronic Idiopathic Constipation
Principal Investigator
Sponsor: Anchen Pharmaceuticals, Inc.
Urology-
Urinary Incontinence A Multicenter, Randomized, Double-Blind, Parallel group Study to Evaluate the Efficacy and Safety of Two Doses of X vs. Placebo in Women with Overactive Bladder
Principal Investigator
Sponsor: Duramed Research, Inc.
A Placebo Controlled Randomized, 12 Week, Dosing-Ranging, Double Blind Study vs. Placebo using Tolterodine as a Study Calibrator, to evaluate Efficacy and Safety of XX in women with Overactive Bladder Including Urge Urinary Incontinence
Principal Investigator
Sponsor: Sanofi-Aventis
A Multicenter, Randomized, Double-Blinded Study to Evaluate the Safety and Efficacy of X Versus Placebo in Women Diagnosed With Overactive Bladder Who Have Symptoms of Predominant or Pure Urge Incontinence, Urgency and Frequency
Principal Investigator
Sponsor: Duramed Research, Inc.
